STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Rigel (Nasdaq: RIGL) will present a company overview at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 8:30 am ET. Dean Schorno, chief financial officer, will deliver the presentation.

Investors can access a live webcast and archived recording via the Investor Relations section of Rigel's website at www.rigel.com; attendees are advised to connect to the site before the start time to allow for any software downloads.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 8:30 am ET.

To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media:
Investors: 
Rigel Pharmaceuticals, Inc. 
650.624.1232 
ir@rigel.com

Media:
David Rosen 
Argot Partners 
646.461.6387
david.rosen@argotpartners.com 

Rigel Pharmaceuticals Logo (PRNewsfoto/Rigel Pharmaceuticals, Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-piper-sandler-37th-annual-healthcare-conference-302626268.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When will Rigel (RIGL) present at the Piper Sandler 2025 conference?

Rigel will present on Wednesday, December 3, 2025 at 8:30 am ET.

Who from Rigel will present at the Piper Sandler 37th Annual Healthcare Conference?

Dean Schorno, Rigel's chief financial officer, will present a company overview.

How can investors watch Rigel's (RIGL) Piper Sandler presentation live or on demand?

Access the live webcast or archived recording via the Investor Relations section at www.rigel.com.

What should viewers do before Rigel's webcast on December 3, 2025?

Viewers should connect to Rigel's website prior to the start to allow time for any required software downloads.

Does Rigel provide investor contacts for the Piper Sandler presentation?

Yes; investor inquiries can be directed to Rigel at 650.624.1232 or ir@rigel.com.
Rigel Pharmaceuticals Inc

NASDAQ:RIGL

RIGL Rankings

RIGL Latest News

RIGL Latest SEC Filings

RIGL Stock Data

903.94M
17.68M
2.65%
79.01%
11.18%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO